Scientists at the John Innes Centre in Norwich, UK, have achieved a significant milestone in biological engineering by successfully growing…
Read More
The Non-GLP-1 Obesity Drug Market Set for Explosive 50-Fold Growth, Reaching $15.5 Billion by 2031
The global pharmaceutical market for obesity treatments is poised for a dramatic transformation, with a burgeoning segment of non-Glucagon-like peptide-1…
Read MoreYOU MAY HAVE MISSED
